MedTech Innovator

MedTech Innovator is a nonprofit funded through corporate sponsorship fees paid by large medical device and health technology companies that gain priority access to the startup pipeline. Corporate sponsors have historically included Johnson & Johnson, Medtronic, Stryker, Intuitive Surgical, and Siemens Healthineers. The organization also receives support from grant-making foundations and industry trade associations.

More than 1,000 medical device, diagnostic, and digital health startups apply annually. A review process involving hundreds of volunteer evaluators from the medtech industry narrows the field to roughly 50 finalists. Those companies participate in a four-month virtual curriculum covering regulatory strategy, reimbursement planning, clinical evidence generation, and commercialization, culminating in an in-person competition and showcase at The MedTech Conference.

MedTech Innovator does not take equity positions or charge participation fees in its flagship program. It awards non-dilutive cash prizes — the primary grand prize was $350,000 in 2023 — and facilitates introductions to corporate sponsors and venture investors, but its legal structure precludes direct equity investment from the parent entity.

Paul Grand, the founder and CEO, oversees the organization's strategy and program design. Selection decisions are made through a structured review process involving internal staff and an external panel of evaluators drawn from sponsoring corporations, experienced medtech executives, and clinicians. Final competition winners are chosen by a live audience vote at the annual showcase event.

MedTech Innovator explicitly focuses on medical devices, diagnostics, and digital health. Pharmaceuticals, biotherapeutics, and pure healthcare services companies are typically out of scope. The organization also requires applicants to have at least a functioning prototype or proof-of-concept; companies at the concept-only stage without any demonstrated feasibility are generally not competitive for the cohort.